“BUPRENORPHINE vs. METADONE IN THE TREATMENT OF OPIOID USE DISORDER DURING PREGNANCY”, RECIMA21, vol. 5, no. 1, p. e514741, Dec. 2023, doi: 10.47820/recima21.v5i1.4741.